Intra-annular fibrin injection is a minimally invasive biologic disc repair procedure that delivers fibrin sealant directly into damaged spinal discs to seal annular tears and support tissue healing. For candidates with chronic discogenic pain, it may offer a non-surgical path to meaningful relief; outcomes vary by individual case and diagnosis.

When Spinal Discs Break Down

Chronic back pain often originates in the spinal discs — the spongy cushions that sit between vertebrae and absorb the forces of daily movement. Each disc has a tough outer ring called the annulus fibrosus and a gel-like inner core called the nucleus pulposus. When the annulus develops tears over time or through injury, the inner material can bulge or leak outward, irritating nearby nerves and producing persistent discogenic pain.

This pattern — frequently associated with degenerative disc disease — is one of the most common structural sources of chronic low back pain. For many patients, the condition becomes persistent, affecting mobility, sleep, and quality of life across months or years. Learn more about how annular tears cause chronic low back pain.

Why Conservative Treatments Often Fall Short

Many patients with chronic discogenic pain cycle through physical therapy, oral medications, and epidural steroid injections. These approaches provide genuine value — physical therapy builds supportive strength and flexibility, medications moderate acute flares, and epidural injections can temporarily calm inflammation. However, none of these treatments address the underlying annular tear itself. When the structural source of pain remains unresolved, symptom relief tends to be temporary, and patients often find themselves repeating the same interventions without durable improvement.

How Intra-Annular Fibrin Injection Works

Fibrin is a naturally occurring protein central to the body’s clotting and tissue-repair processes. When tissue is damaged, fibrin forms a mesh-like scaffold that stops further injury and creates a framework for healing cells to regenerate. Intra-annular fibrin injection applies this same biologic principle directly to damaged spinal discs.

During the procedure, our clinical team uses fluoroscopic imaging to guide a needle precisely into the affected disc. A concentrated fibrin sealant is then delivered directly into the annular defect — a targeted, image-guided approach that does not require incisions, general anesthesia, or hospital admission.

Once in place, the fibrin may work on several levels:

• Sealing the tear: The fibrin creates a structural barrier across the annular defect, limiting further leakage of the nucleus pulposus and reducing mechanical irritation of nearby nerve tissue.
• Supporting biological repair: The fibrin matrix acts as a scaffold, encouraging the body’s own healing cells and growth factors to migrate into the damaged area — supporting regeneration of annular tissue rather than simply masking pain signals.
• Restoring disc function: By targeting the structural source of pain, the treatment aims to improve disc integrity and reduce the mechanical forces driving ongoing symptoms, though individual outcomes vary by case.

Expert Take

Our clinical team evaluates each candidate individually before recommending fibrin disc treatment. The procedure is best suited for patients whose imaging confirms symptomatic annular tears that have not responded to conservative care. Candidacy is not determined by symptom severity alone — precise diagnostic correlation between imaging findings and clinical presentation is essential before proceeding.

Fibrin Disc Treatment vs. Spinal Fusion Surgery

For many years, spinal fusion was the primary surgical option offered when conservative treatments failed. Fusion involves permanently joining two or more vertebrae — a significant structural change that eliminates motion at the treated segment. While fusion is appropriate in specific clinical scenarios, it carries meaningful trade-offs that candidates should understand before proceeding.

Limitations of Spinal Fusion

• Suboptimal outcomes in a substantial portion of patients: Published data indicates that many fusion surgeries do not achieve the intended result. A well-documented sequela — Failed Back Surgery Syndrome (FBSS) — affects a meaningful percentage of patients following lumbar spine operations.
• Loss of segmental motion: Fusing vertebrae eliminates natural movement at that level. Over time, this redistributes mechanical load to adjacent discs — a process called adjacent segment disease — which may accelerate degeneration nearby and require further intervention in some patients.
• Extended recovery: Recovery from spinal fusion typically spans several months and involves significant activity restrictions and structured physical rehabilitation.
• Surgical risks: As a major open procedure, fusion carries risks of infection, blood loss, hardware complications, and nerve injury that are not present with minimally invasive alternatives.

How Fibrin Disc Treatment Differs

Intra-annular fibrin injection takes a fundamentally different approach. Rather than altering spinal anatomy, it works with the body’s own repair mechanisms to address the structural source of disc pain — without permanently changing how the spine moves. Key distinctions include:

• Minimally invasive: The procedure requires only a needle puncture under image guidance — no incisions, no hardware implantation, no general anesthesia.
• Motion preservation: Vertebrae are not fused. The natural biomechanics of the spine are maintained, avoiding the cascade of adjacent segment stress associated with fusion.
• Biologic repair goal: Rather than stabilizing a painful segment by eliminating its movement, the fibrin procedure targets healing of the underlying annular tear.
• Shorter recovery trajectory: Many candidates return to normal activity on a meaningfully shorter timeline than fusion surgery requires, though individual recovery varies.

In clinical studies examining fibrin injection outcomes, patients reported meaningful reductions in pain scores over a two-year follow-up period, and a majority reported satisfaction with their results at that timeframe. Among patients who had previously undergone spine surgery and continued to experience pain — a condition known as Failed Back Surgery Syndrome — a substantial portion reported positive outcomes following fibrin treatment. These figures reflect studied populations; individual results vary based on diagnosis, history, and case-specific factors.

Who May Be a Candidate for Annular Tear Repair

Intra-annular fibrin injection is evaluated for patients with chronic back pain — typically lasting more than six months — that is attributable to symptomatic annular tears confirmed on MRI. Common presentations include persistent low back pain worsened by sitting, bending, or lifting, and discomfort that may radiate into the buttocks or thighs.

Candidates are evaluated individually. A thorough assessment includes a detailed clinical history, physical examination, and careful correlation of imaging findings with reported symptoms. The goal is to confirm that the annular tear — rather than another structural source — is the primary pain generator before recommending treatment.

This option may be particularly relevant for patients who have not found lasting relief through conservative care and want to explore non-surgical paths before committing to major surgery. It may also be appropriate for those who have undergone prior spine procedures and continue to experience significant pain. See when regenerative disc repair is worth considering before surgery.

A Non-Surgical Path Worth Evaluating

Our clinical team believes patients with chronic discogenic pain deserve a thorough evaluation of all available options before proceeding to fusion. Intra-annular fibrin injection represents a biologically grounded, minimally invasive approach that targets the structural source of disc pain without altering spinal anatomy or eliminating motion.

Whether this treatment is appropriate depends on each individual’s diagnostic profile, treatment history, and goals. We encourage anyone considering spine surgery to first explore whether a non-surgical approach may address their specific condition.

Ready to discuss whether fibrin disc treatment may be right for you? Contact our clinical team to schedule an evaluation.

For a broader overview of non-surgical spine care options, we recommend: 7 Best Spinal Fusion Alternatives: A Patient’s Guide